FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317360183> ?p ?o ?g. }

• W4317360183 endingPage "416" @default.
• W4317360183 startingPage "415" @default.
• W4317360183 abstract "The impact of the coronavirus disease 2019 (COVID-19) may be alleviated by dissemination of vaccines, of which messenger ribonucleic acid (mRNA) is an important subtype. As of January 2022, over 50% of the population is double vaccinated with developing policies that encourage the remainder of the population to complete vaccination. Vaccinations have demonstrated a 10-fold decrease in COVID-related hospitalizations and mortality, with recent evidence of boosters associated with another 10-fold decrease in COVID-related mortality.1 There is also an evolving necessity to understand mRNA vaccination beyond COVID-19, with its application in the prevention of other viral infections and cancer treatment, so ophthalmologists must be aware of possible associations with ocular conditions and be able to provide patients with well-informed advice in the future.2 This correspondence highlights important questions relevant to ophthalmologists to better understand the association of mRNA-based COVID-19 vaccination with ocular disease, and practical considerations in patient counselling and relevant clinical questions.3 Ultimately, any medical intervention should involve informed consent and the possibility of preemptive measures may be considered, while preserving the upmost necessity for vaccination. The safety profiles of COVID-19 vaccines have been widely reported; however, there remains limited data for patients with ophthalmological disease. There is no unifying literature that definitively links ophthalmic disease and COVID-19 vaccination, so our understanding is limited to case reports and series, as presented in Supplementary Digital Content Table 1 (https://links.lww.com/APJO/A168). Associations have been implicated for cornea and external eye, ocular inflammation, retina, neuro-ophthalmology, and orbital disease. Authors describe favorable outcomes and disease control for a vast majority of ophthalmic complications potentially associated with COVID-19 vaccination. Hypothesized mechanisms that may cause ophthalmic events include the use of adjuvants in mRNA vaccinations that stimulate innate immunity through cytoplasmic nucleic acid receptors, and particularly affect autoimmune disease associated with altered nucleic acid metabolism.4 It is still important to consider whether the ocular conditions described are incidental in their timing from recently receiving a COVID-19 vaccination, or whether there is a true causative explanation. Careful pharmacovigilance of mRNA vaccinations, especially in the setting of rapid progression from development to utility is essential in firstly safeguarding our population with robust adverse event monitoring and establishing public trust. There is significant scrutiny on COVID-19 vaccine adverse events; however, ophthalmic sequalae of vaccinations are not new. Well-established, yet broadly accepted vaccinations, such as the live-attenuated measles-mumps-rubella, nasal spray influenza vaccine, rotavirus vaccine, yellow fever vaccine, and original live attenuated varicella vaccine have been associated with complications too.5 Among these vaccines, major ophthalmic manifestations reported include uveitis, optic neuritis, corneal ulceration, and central retinal artery occlusion, estimated at 1 per 100,000.6 Ophthalmologists remain in ongoing dilemma for the treatment of patients with COVID-19 infection that have ocular conditions requiring immunosuppression.7 In terms of management, there is no evidence for prophylactic treatment of patients with preexisting disease, such as uveitis or herpes zoster ophthalmicus, who will be planning to have COVID-19 vaccination or have active infection. Although ophthalmic complications from COVID-19 vaccination are undesirable, COVID-19 infection causing ocular disease are more common and may result in more severe outcomes. In addition to conditions associated with vaccination described in our supplmentary data (https://links.lww.com/APJO/A168), COVID-19 infection can cause retinal disease, for example, acute retinal necrosis, nonspecific peripheral retinal hemorrhages, macular hyperpigmentation, retinal sectoral pallor, hard exudates, and cotton wool spots have been described.8 Serious orbital disease associated with COVID-19 infection have included orbital cellulitis and mucormycosis.9 There are currently no recommendations regarding the timing of COVID-19 vaccinations specifically in relation to ocular procedures or surgery. Preoperative vaccination at least 2 weeks before surgery has been associated with lower rates of postoperative morbidity across broad surgical disciplines.10 Understanding this topic is important so that ophthalmologists may appropriately counsel patients on potential associations with the COVID-19 vaccination and allow for early identification of disease requiring management. Beyond the COVID-19 pandemic, literature about ophthalmic associations of mRNA vaccination will additionally be valuable to guide risk management for its evolving utility in other therapy. Brad Guo, MBBS, MMed and Rahul Chakrabarti, BMedSc, MSurgEd" @default.
• W4317360183 created "2023-01-19" @default.
• W4317360183 creator A5039153652 @default.
• W4317360183 creator A5042583944 @default.
• W4317360183 date "2022-11-04" @default.
• W4317360183 modified "2023-09-26" @default.
• W4317360183 title "Causation or Association: Important Considerations for mRNA Vaccines in Patients With Ophthalmic Disease: The COVID-19 Pandemic and Beyond" @default.
• W4317360183 cites W2000920812 @default.
• W4317360183 cites W2782708334 @default.
• W4317360183 cites W3034395824 @default.
• W4317360183 cites W3086125080 @default.
• W4317360183 cites W3092680180 @default.
• W4317360183 cites W3133745688 @default.
• W4317360183 cites W4200177230 @default.
• W4317360183 cites W4225908550 @default.
• W4317360183 cites W4226343618 @default.
• W4317360183 doi "https://doi.org/10.1097/apo.0000000000000532" @default.
• W4317360183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37523434" @default.
• W4317360183 hasPublicationYear "2022" @default.
• W4317360183 type Work @default.
• W4317360183 citedByCount "0" @default.
• W4317360183 crossrefType "journal-article" @default.
• W4317360183 hasAuthorship W4317360183A5039153652 @default.
• W4317360183 hasAuthorship W4317360183A5042583944 @default.
• W4317360183 hasBestOaLocation W43173601831 @default.
• W4317360183 hasConcept C142724271 @default.
• W4317360183 hasConcept C177713679 @default.
• W4317360183 hasConcept C203014093 @default.
• W4317360183 hasConcept C22070199 @default.
• W4317360183 hasConcept C2779134260 @default.
• W4317360183 hasConcept C2908647359 @default.
• W4317360183 hasConcept C3008058167 @default.
• W4317360183 hasConcept C512399662 @default.
• W4317360183 hasConcept C524204448 @default.
• W4317360183 hasConcept C71924100 @default.
• W4317360183 hasConcept C89623803 @default.
• W4317360183 hasConcept C99454951 @default.
• W4317360183 hasConceptScore W4317360183C142724271 @default.
• W4317360183 hasConceptScore W4317360183C177713679 @default.
• W4317360183 hasConceptScore W4317360183C203014093 @default.
• W4317360183 hasConceptScore W4317360183C22070199 @default.
• W4317360183 hasConceptScore W4317360183C2779134260 @default.
• W4317360183 hasConceptScore W4317360183C2908647359 @default.
• W4317360183 hasConceptScore W4317360183C3008058167 @default.
• W4317360183 hasConceptScore W4317360183C512399662 @default.
• W4317360183 hasConceptScore W4317360183C524204448 @default.
• W4317360183 hasConceptScore W4317360183C71924100 @default.
• W4317360183 hasConceptScore W4317360183C89623803 @default.
• W4317360183 hasConceptScore W4317360183C99454951 @default.
• W4317360183 hasIssue "4" @default.
• W4317360183 hasLocation W43173601831 @default.
• W4317360183 hasLocation W43173601832 @default.
• W4317360183 hasLocation W43173601833 @default.
• W4317360183 hasOpenAccess W4317360183 @default.
• W4317360183 hasPrimaryLocation W43173601831 @default.
• W4317360183 hasRelatedWork W3103289217 @default.
• W4317360183 hasRelatedWork W3106370311 @default.
• W4317360183 hasRelatedWork W3108360120 @default.
• W4317360183 hasRelatedWork W3119540162 @default.
• W4317360183 hasRelatedWork W3152606407 @default.
• W4317360183 hasRelatedWork W3152916563 @default.
• W4317360183 hasRelatedWork W4313474620 @default.
• W4317360183 hasRelatedWork W4327956415 @default.
• W4317360183 hasRelatedWork W4381432928 @default.
• W4317360183 hasRelatedWork W4381942459 @default.
• W4317360183 hasVolume "12" @default.
• W4317360183 isParatext "false" @default.
• W4317360183 isRetracted "false" @default.
• W4317360183 workType "article" @default.